Venous thromboembolism in patients with adrenocortical carcinoma after surgery
Background: Adrenocortical carcinoma is a rare malignancy with a poor prognosis. We hypothesized that patients with adrenocortical carcinoma are at high risk for venous thromboembolism, given the numerous risk factors such as malignancy, abdominal surgery, immobility and hormonal excess. The aim of...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2020-09-01
|
Series: | Endocrine Connections |
Subjects: | |
Online Access: | https://ec.bioscientifica.com/view/journals/ec/9/9/EC-20-0299.xml |
id |
doaj-d365cfdfd30b43149d28caa43ae1e18f |
---|---|
record_format |
Article |
spelling |
doaj-d365cfdfd30b43149d28caa43ae1e18f2020-11-25T01:55:10ZengBioscientificaEndocrine Connections2049-36142049-36142020-09-0199874881https://doi.org/10.1530/EC-20-0299Venous thromboembolism in patients with adrenocortical carcinoma after surgeryJülide Durmuşoğlu0Henri J L M Timmers1Pepijn van Houten2Hans F Langenhuijsen3Ad R M M Hermus4Annenienke C van de Ven5Division of Endocrinology, Department of Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, the NetherlandsDivision of Endocrinology, Department of Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, the NetherlandsDivision of Endocrinology, Department of Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, the NetherlandsDepartment of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, the NetherlandsDivision of Endocrinology, Department of Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, the NetherlandsDivision of Endocrinology, Department of Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, the NetherlandsBackground: Adrenocortical carcinoma is a rare malignancy with a poor prognosis. We hypothesized that patients with adrenocortical carcinoma are at high risk for venous thromboembolism, given the numerous risk factors such as malignancy, abdominal surgery, immobility and hormonal excess. The aim of this study was to determine retrospectively the incidence of venous thromboembolisms after surgical treatment in patients with adrenocortical carcinoma. Materials and methods: A retrospective study was performed, collecting data from all patients diagnosed with adrenocortical carcinoma from 2003 to 2018 at the Radboud University Medical Centre, The Netherlands. Results: In 34 patients, eight postoperative venous thromboembolisms, all pulmonary embolisms, were diagnosed in the first 6 months after adrenalect omy (23.5%). In addition, one patient developed pulmonary embolism just prior to surgery and one patient 7 years after surgery. Five of the eight patients with postoperative venous thromboembolisms presented with symptomatic pulmonary embolism whereas the other three pulmonary embolisms were incidentally found on regular follow up CT scans. Seven of the eight venous thromboembolisms occurred within 10 weeks after surgery. Seven of the eight patients had advanced stage adrenocortical carcinoma and four patients already received low-molecular weight heparin during the development of the venous thromboembolism. There was one case of fatal pulmonary embolism in a patient with a cortisol producing tumor with pulmonary metastases, despite the use of a therapeutic dose thromboprophylaxis. Conclusion: Patients with adrenocortical carcinoma are at high risk of developing postoperative venous thromboembolisms. Prolonged postoperative thromboprophylaxis could be considered in these patients. https://ec.bioscientifica.com/view/journals/ec/9/9/EC-20-0299.xmladrenocortical carcinomavenous thromboembolismincidencesurgerypostoperative |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jülide Durmuşoğlu Henri J L M Timmers Pepijn van Houten Hans F Langenhuijsen Ad R M M Hermus Annenienke C van de Ven |
spellingShingle |
Jülide Durmuşoğlu Henri J L M Timmers Pepijn van Houten Hans F Langenhuijsen Ad R M M Hermus Annenienke C van de Ven Venous thromboembolism in patients with adrenocortical carcinoma after surgery Endocrine Connections adrenocortical carcinoma venous thromboembolism incidence surgery postoperative |
author_facet |
Jülide Durmuşoğlu Henri J L M Timmers Pepijn van Houten Hans F Langenhuijsen Ad R M M Hermus Annenienke C van de Ven |
author_sort |
Jülide Durmuşoğlu |
title |
Venous thromboembolism in patients with adrenocortical carcinoma after surgery |
title_short |
Venous thromboembolism in patients with adrenocortical carcinoma after surgery |
title_full |
Venous thromboembolism in patients with adrenocortical carcinoma after surgery |
title_fullStr |
Venous thromboembolism in patients with adrenocortical carcinoma after surgery |
title_full_unstemmed |
Venous thromboembolism in patients with adrenocortical carcinoma after surgery |
title_sort |
venous thromboembolism in patients with adrenocortical carcinoma after surgery |
publisher |
Bioscientifica |
series |
Endocrine Connections |
issn |
2049-3614 2049-3614 |
publishDate |
2020-09-01 |
description |
Background: Adrenocortical carcinoma is a rare malignancy with a poor prognosis. We hypothesized that patients with adrenocortical carcinoma are at high risk for venous thromboembolism, given the numerous risk factors such as malignancy, abdominal surgery, immobility and hormonal excess. The aim of this study was to determine retrospectively the incidence of venous thromboembolisms after surgical treatment in patients with adrenocortical carcinoma.
Materials and methods: A retrospective study was performed, collecting data from all patients diagnosed with adrenocortical carcinoma from 2003 to 2018 at the Radboud University Medical Centre, The Netherlands.
Results: In 34 patients, eight postoperative venous thromboembolisms, all pulmonary embolisms, were diagnosed in the first 6 months after adrenalect omy (23.5%). In addition, one patient developed pulmonary embolism just prior to surgery and one patient 7 years after surgery. Five of the eight patients with postoperative venous thromboembolisms presented with symptomatic pulmonary embolism whereas the other three pulmonary embolisms were incidentally found on regular follow up CT scans. Seven of the eight venous thromboembolisms occurred within 10 weeks after surgery. Seven of the eight patients had advanced stage adrenocortical carcinoma and four patients already received low-molecular weight heparin during the development of the venous thromboembolism. There was one case of fatal pulmonary embolism in a patient with a cortisol producing tumor with pulmonary metastases, despite the use of a therapeutic dose thromboprophylaxis.
Conclusion: Patients with adrenocortical carcinoma are at high risk of developing postoperative venous thromboembolisms. Prolonged postoperative thromboprophylaxis could be considered in these patients.
|
topic |
adrenocortical carcinoma venous thromboembolism incidence surgery postoperative |
url |
https://ec.bioscientifica.com/view/journals/ec/9/9/EC-20-0299.xml |
work_keys_str_mv |
AT julidedurmusoglu venousthromboembolisminpatientswithadrenocorticalcarcinomaaftersurgery AT henrijlmtimmers venousthromboembolisminpatientswithadrenocorticalcarcinomaaftersurgery AT pepijnvanhouten venousthromboembolisminpatientswithadrenocorticalcarcinomaaftersurgery AT hansflangenhuijsen venousthromboembolisminpatientswithadrenocorticalcarcinomaaftersurgery AT adrmmhermus venousthromboembolisminpatientswithadrenocorticalcarcinomaaftersurgery AT annenienkecvandeven venousthromboembolisminpatientswithadrenocorticalcarcinomaaftersurgery |
_version_ |
1724984660943962112 |